Sham Administration

OTHER2 trials

Sponsors

AbbVie, Annexon, Inc.

Conditions

Geographic AtrophyOcular HypertensionOpen-angle Glaucoma

Phase 1

AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension

RecruitingNCT04499248

AbbVieOcular Hypertension, Open-angle Glaucoma

Start: 2020-11-16End: 2029-02-01Target: 96Updated: 2026-03-23

Phase 3

A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Geographic Atrophy (GA)

Active, not recruitingNCT06510816

Annexon, Inc.Geographic Atrophy

Start: 2024-07-30End: 2027-10-31Updated: 2025-11-06